Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An epidemiologic study to determine the prevalence of the HLA-B*5701 allele among HIV-positive patients in Europe.

Pharmacogenetics and genomics - 1 May 2010

Orkin Chloe, Wang Jianmin, Bergin Colm, Molina Jean-Michel, Lazzarin Adriano, Cavassini Matthias, Esser Stefan, Gómez Sirvent Juan-Luis, Pearce Helen

Abstract excerpt

OBJECTIVES: HLA-B*5701 is a major histocompatibility complex class I allele associated with an immunologically-mediated hypersensitivity reaction to abacavir. The objectives of this study were to evaluate HLA-B*5701 prevalence among European, HIV-1-infected patients and to compare the local and c...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Europe
Share to HIV Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Seropositivity

Share to HLA-B Antigens

Share to Predictive Value of Tests

Share to Prevalence

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 20375757
DOI: 10.1097/FPC.0b013e3283390666

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20375757-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An epidemiologic study to determine the prevalence of the HLA-B*5701 allele among HIV-positive patients in Europe.PMID 20375757Read ↗

Prospective epidemiological study of the prevalence of human leukocyte antigen (HLA)-B*5701 in HIV-1-infected UK subjects.Semantic proximity Read ↗

HLA-B*5701 frequency in Chilean HIV-infected patients and in general population.Semantic proximity Read ↗

External quality assessment of HLA-B*5701 reporting: an international multicentre survey.Semantic proximity Read ↗

High Frequency of Human Leukocyte Antigen-B*57:01 Allele Carriers among HIV-Infected Patients in Serbia.Semantic proximity Read ↗

HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjectsSemantic proximity Read ↗

Prevalence of Human Leukocyte Antigen HLA-B*57:01 in Individuals with HIV in West and Central AfricaSemantic proximity Read ↗

Prevalence of HLA-B*57:01 allele in Argentinean HIV-1 infected patients.Semantic proximity Read ↗

Prevalence of HLA-B*57:01 and complete linkage disequilibrium with HCP5 rs2395029: Prevalence and DetectionSemantic proximity Read ↗

HLA-B*5701 genetic screening among HIV-1 infected patients in Hong Kong: is this a practical approach in Han-Chinese?Semantic proximity Read ↗

Current trends in screening across ethnicities for hypersensitivity to abacavir.Semantic proximity Read ↗

HLA-B*5701 Allele Prevalence in Treatment-Naïve HIV-Infected Patients from ColombiaSemantic proximity Read ↗

HLA-B*5701 screening for hypersensitivity to abacavir.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.